Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
35 Results
Available On-Demand
AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of…
AnHeart Therapeutics is an oncology-focused clinical stage biopharmaceutical company headquartered…
Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for…
Cend is a clinical-stage biotech company focused on a novel approach to enhance and more…
Conagen is a rapidly growing synthetic biology and bio-manufacturing company. We specialize in the…
Cybrexa is a privately-held biotechnology company dedicated to developing next-generation tumor…
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) is a biopharmaceutical company…
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is…
Elpiscience is a clinical stage biopharmaceutical company focusing on cancer immunotherapy. The…
Elucida Oncology, Inc., is a biotechnology company pioneering the next frontier in targeted cancer…
Enzychem Lifesciences (KOSDAQ:183490) is developing novel small molecule therapeutics to target…

ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based…

EV Therapeutics is a pre-clinical stage start-up developing a novel immune checkpoint inhibitor…
Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory…
Geistlich Pharma, a family-owned Swiss company, is a world leader in the field of biomaterials and…
We are focused on the development of stem cell-derived Natural Killer cells (NK cells) as a…
Greenwich LifeSciences (Nasdaq: GLSI) is a public biopharmaceutical company located in Houston, TX…
Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to…
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company…
Founded by biotech pioneers Lee Hood, Jim Heath and Al Luderer, Indi Molecular is developing fully…
Infinity is advancing eganelisib, a first-in-class, oral immuno-oncology development candidate that…
Loki focuses on treating solid tumors and metastases through the activation and redirection of…
Morphogenesis is a clinical stage cell/gene therapy company focusing on a platform of cancer…
Notable is redefining cancer treatment by taking a functional approach to precision oncology in…
OncoMyx is developing potentially best-in-class (multi-armed, IV/systemically-delivered, precision…
Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel…
Osmol, a development stage biopharma company, is advancing a novel treatment to prevent…
Plus Therapeutics (Nasdaq: PSTV) is a clinical-stage pharmaceutical company whose radiotherapeutic…
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting…
RubrYc Therapeutics is a preclinical precision oncology company that uses a proprietary engineering…
Servier is an international pharmaceutical company governed by a non-profit foundation, with its…
We are a late-stage biopharmaceutical company committed to developing and commercializing products…
TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the…
VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharmaceutical company…
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the…